Publicaciones en colaboración con investigadores/as de University of Connecticut (8)

2022

  1. Corrigendum to ‘Non-ionic surfactant vesicles as novel delivery systems for sulfasalazine: Evaluation of the physicochemical and cytotoxic properties’ [Journal of Molecular Structure 1230 (2021) 129874] (Journal of Molecular Structure (2021) 1230, (S0022286021000053), (10.1016/j.molstruc.2021.129874))

    Journal of Molecular Structure

2021

  1. Non-ionic surfactant vesicles as novel delivery systems for sulfasalazine: Evaluation of the physicochemical and cytotoxic properties

    Journal of Molecular Structure, Vol. 1230

2003

  1. Compounds acting at the endocannabinoid and/or endovanilloid systems reduce hyperkinesia in a rat model of Huntington's disease

    Journal of Neurochemistry, Vol. 84, Núm. 5, pp. 1097-1109

1999

  1. Cannabinoid receptor and WIN-55,212-2-stimulated [35S]GTPγS binding and cannabinoid receptor mRNA levels in several brain structures of adult male rats chronically exposed to R-methanandamide

    Neurochemistry International, Vol. 34, Núm. 6, pp. 473-482

  2. Extrapyramidal and neuroendocrine effects of AM404, an inhibitor of the carrier-mediated transport of anandamide

    Life Sciences, Vol. 65, Núm. 3, pp. 327-336

1998

  1. Effects of cannabinoids on prolactin and gonadotrophin secretion: Involvement of changes in hypothalamic γ-aminobutyric acid (GABA) inputs

    Biochemical Pharmacology, Vol. 56, Núm. 10, pp. 1331-1338

1997

  1. Time course of the effects of different cannabimimetics on prolactin and gonadotrophin secretion: Evidence for the presence of CB 1 receptors in hypothalamic structures and their involvement in the effects of cannabimimetics

    Biochemical Pharmacology, Vol. 53, Núm. 12, pp. 1919-1927

1996

  1. Extrapyramidal effects of methanandamide, an analog of anandamide, the endogenous CB1 receptor ligand

    Life Sciences, Vol. 58, Núm. 15, pp. 1249-1257